Osiris Therapeutics, Inc. (NASDAQ:OSIR)

CAPS Rating: 1 out of 5

A stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas.

Recs

0
Player Avatar pchop123 (76.57) Submitted: 7/30/2012 9:27:45 PM : Underperform Start Price: $9.15 OSIR Score: +8.56

almost a sure bet to keep dropping

Featured Broker Partners


Advertisement